On Wednesday, Following Stocks were among the “Top 50 Losers” of U.S. Stock Market: StemCells Inc (NASDAQ:STEM), VAALCO Energy, Inc (NYSE:EGY), Navistar International Corp (NYSE:NAV), RadNet Inc (NASDAQ:RDNT)
StemCells Inc (NASDAQ:STEM), with shares declined -4.55%, closed at $1.05.
VAALCO Energy, Inc (NYSE:EGY), with shares dropped -3.93%, settled at $3.42, hitting new 52-week low of $3.33.
Navistar International Corp (NYSE:NAV), with shares dipped -3.93%, and closed at $29.34.
RadNet Inc (NASDAQ:RDNT), plummeted -1.77%, and closed at $7.76.
Latest NEWS regarding these Stocks are depicted underneath:
StemCells Inc. (NASDAQ:STEM)
StemCells Inc. (STEM), offered a business update and stated financial results for the fourth quarter and year ended December 31, 2014.
“We achieved three noteworthy clinical translation milestones in 2014: the completion of enrollment in two Phase I/II studies and initiation of the first of two planned, multicenter Phase II proof of concept studies using our proprietary human neural stem cell platform,” said Martin McGlynn, President and CEO of StemCells, Inc. “The first of the Phase I/II studies is in thoracic spinal cord injury and the second in dry age-related macular degeneration. The aim of the first Phase II study, known as the Pathway Study(TM) is to evaluate the ability of the cells to restore motor function to the upper extremities in cervical spinal cord injuries. We will shortly initiate a controlled proof-of-concept Phase II study in geographic atrophy of dry age related macular degeneration, the most advanced form of the disease and a leading cause of blindness in the elderly.”
For the fourth quarter of 2014, the Corporation stated a net loss of $10,108,000 from ongoing operations and a net loss of $141,000 from suspended operations for a total net loss of $10,249,000 or $(0.15) per share. In comparison, for the fourth quarter of 2013, the Corporation stated a net loss of $6,848,000 from ongoing operations and a net loss of $115,000 from suspended operations for a total net loss of $6,963,000, or $(0.13) per share.
StemCells, Inc., a biopharmaceutical corporation, is engaged in the research, development, and commercialization of stem cell therapeutics, and related tools and technologies for stem cell-based research and drug discovery and development.
Vaalco Energy Inc. (NYSE:EGY)
On Monday, Vaalco Energy Inc. (EGY), stated results for the fourth quarter and full-year 2014.
For the 2014 fourth quarter, VAALCO stated Adjusted Net Revenue of $9 thousand, or $0.00 per diluted share. Adjusted Net Revenue excludes a $98.3 million non-cash impairment charge related to significantly lower projected oil prices used in the impairment valuation for the Etame, Ebouri, and Southeast Etame/North Tchibala fields, offshore Gabon as described below. Counting this charge, our stated net loss was $98.3 million, or a loss of $1.70 per share. The fourth quarter 2014 results were influenced by the substantial recent fall in oil prices and lower amounts of oil lifted from the Corporation’s offshore Gabon operations. These financial results compare with net revenue of $26.4 million, or $0.46 per diluted share, for the comparable period in 2013.
For the year ended December 31, 2014, VAALCO stated Adjusted Net Revenue of $20.8 million, or $0.36 per diluted share, before the non-cash impairment charge related to projected oil prices used in the impairment valuation for the Etame Field, Ebouri Field, and Southeast Etame/North Tchibala fields, offshore Gabon. Counting this impairment charge of $98.3 million, the Corporation’s stated net loss was $77.6 million, or $1.36 per diluted share, contrast to net revenue of $43.1 million, or $0.74 per diluted share, for the year ended December 31, 2013. The decrease in net revenue for full year 2014, contrast to the same period in 2013, is primarily attributable to the impairment charge and due to lower proceed resulting from the influence of the decline in oil prices and lower amounts of barrels lifted from Corporation’s offshore Gabon operations.
In the year ended December 31, 2014, the Corporation produced on a gross basis about 5,803,000 barrels of crude oil (“Bbls”) (1,417,000 Bbls net to the Corporation), contrast to about 6,244,000 Bbls (1,525,000 Bbls net to the Corporation) for the year ended December 31, 2013. In the fourth quarter of 2014, the Corporation produced on a net basis about 333,000 Bbls from its offshore Gabon operations contrast to 405,000 Bbls produced in the fourth quarter of 2013.
VAALCO Energy, Inc., an independent energy corporation, attains, explores for, develops, and produces crude oil and natural gas. The corporation owns producing properties and conducts exploration activities as an operator of consortiums internationally in Gabon and Angola, in addition to conducts exploration activities as a non-operator in Equatorial Guinea, West Africa.
Navistar International Corporation (NYSE:NAV)
Formerly on March 10, Navistar International Corporation (NAV), presented the fifth annual Influential Woman in Trucking award to Kari Rihm, president and CEO, Rihm Kenworth, at a ceremony during this week’s Truckload Carriers Association (TCA) annual meeting.
The Influential Woman in Trucking award recognizes women in the trucking industry who make or influence key decisions, have a proven record of responsibility, and mentor and serve as a role model to other women. WIT and Navistar teamed up to develop this award in 2010 as a way to honor female leaders in trucking, and to attract and advance women within the industry.
Rihm Kenworth is the only 100 percent woman-owned Kenworth dealer in the United States. Rihm took over Rihm Kenworth after the passing of her husband in 2010. The corporation, based in St. Paul, Minn., has been in her husband’s family since 1932. With assist from her two children, who represent the fourth generation at the dealership, and other dedicated employees, Rihm Kenworth has since added two additional locations, growing from three to five dealerships. They have also raised headcount by over 50 percent, been the Kenworth Truck Corporation Medium Duty Truck Dealer of the Year three out of the last four years, and have been certified by the Womens Business Enterprise Network Council (WBENC) since 2011.
The Women In Trucking Association (www.WomenInTrucking.org) was established to encourage the employment of women in the trucking industry, promote their accomplishments and minimize the obstacles they face while building their careers.
Navistar International Corporation manufactures and sells commercial and military trucks, diesel engines, and school and commercial buses; and provides service parts for trucks and diesel engines worldwide. It operates through four segments: North America Truck, North America Parts, Global Operations, and Financial Services.
RadNet, Inc. (NASDAQ:RDNT)
RadNet, Inc. (RDNT), stated financial results for its fourth quarter and full year ended December 31, 2014.
For the fourth quarter of 2014, RadNet stated Proceed of $185.6 million, Adjusted EBITDA(1) of $32.0 million and Net Revenue of $4.2 million. Proceed raised $7.2 million (or 4.0%), Adjusted EBITDA(1) raised $150,000 (or 0.5%) and Net Revenue raised $3.0 million (or 238.3%) over the fourth quarter of 2013.
Net Revenue for the fourth quarter was $0.10 per diluted share, contrast to a Net Revenue of $0.03 per diluted share in the fourth quarter of 2013. These per share values are based upon a weighted average number of diluted shares outstanding of 44.2 million in the fourth quarter of 2014 and 39.6 million of diluted shares outstanding in the fourth quarter of 2013.
For the fourth quarter of 2014, as contrast with the preceding year’s fourth quarter, MRI volume raised 9.4%, CT volume raised 16.3% and PET/CT volume raised 3.9%. Overall volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, raised 10.5% over the preceding year’s fourth quarter. On a same-center basis, counting only those centers which were part of RadNet for both the fourth quarters of 2014 and 2013, MRI volume raised 7.1%, CT volume raised 14.1% and PET/CT volume raised 3.8%. Overall same-center volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, raised 7.3% over the preceding year’s same quarter.
RadNet, Inc. provides outpatient diagnostic imaging services in the United States. It offers various imaging services, counting magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy, and other related procedures.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
